$QXO
QXO, Inc.

2023 Q3 Form 10-Q Financial Statement

#000118518523000784 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $13.42M $13.26M
YoY Change 22.96% 24.62%
Cost Of Revenue $8.073M $8.072M
YoY Change 24.42% 23.98%
Gross Profit $5.350M $5.185M
YoY Change 20.81% 25.63%
Gross Profit Margin 39.86% 39.11%
Selling, General & Admin $4.726M $4.525M
YoY Change 10.91% 15.32%
% of Gross Profit 88.34% 87.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $75.31K $85.53K
YoY Change -22.13% -11.44%
% of Gross Profit 1.41% 1.65%
Operating Expenses $4.923M $4.729M
YoY Change 8.28% 12.42%
Operating Profit $427.5K $456.3K
YoY Change -463.45% -675.76%
Interest Expense $7.647K $17.42K
YoY Change -67.72% -26.8%
% of Operating Profit 1.79% 3.82%
Other Income/Expense, Net -$2.994M -$17.42K
YoY Change 12538.27% -26.8%
Pretax Income -$2.566M $438.8K
YoY Change 1716.23% -525.87%
Income Tax -$456.1K $95.48K
% Of Pretax Income 21.76%
Net Earnings -$2.110M $343.4K
YoY Change 1471.98% -491.22%
Net Earnings / Revenue -15.72% 2.59%
Basic Earnings Per Share -$0.40 $0.07
Diluted Earnings Per Share -$0.40 $0.07
COMMON SHARES
Basic Shares Outstanding 5.256M shares 5.256M shares
Diluted Shares Outstanding 5.256M shares 5.256M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.880M $7.130M
YoY Change -4.87% 21.39%
Cash & Equivalents $6.880M $7.130M
Short-Term Investments
Other Short-Term Assets $1.120M $3.568M
YoY Change -47.67% 140.23%
Inventory
Prepaid Expenses
Receivables $2.695M $2.228M
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.04M $13.43M
YoY Change -8.11% 34.94%
LONG-TERM ASSETS
Property, Plant & Equipment $532.8K $557.1K
YoY Change -33.93% -37.75%
Goodwill $1.140M $1.140M
YoY Change 12.65% 12.65%
Intangibles $3.779M $3.941M
YoY Change -17.04% -17.01%
Long-Term Investments
YoY Change
Other Assets $180.6K $187.6K
YoY Change -3.69% -0.69%
Total Long-Term Assets $7.349M $7.177M
YoY Change -7.76% -14.16%
TOTAL ASSETS
Total Short-Term Assets $11.04M $13.43M
Total Long-Term Assets $7.349M $7.177M
Total Assets $18.39M $20.60M
YoY Change -7.97% 12.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.502M $2.821M
YoY Change 37.54% 45.19%
Accrued Expenses $2.830M $2.175M
YoY Change 33.11% 51.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $103.3K
YoY Change -100.0% 0.0%
Long-Term Debt Due $413.9K $477.1K
YoY Change -34.94% -10.0%
Total Short-Term Liabilities $10.55M $9.469M
YoY Change 16.18% 31.51%
LONG-TERM LIABILITIES
Long-Term Debt $381.3K $451.7K
YoY Change -52.04% -53.95%
Other Long-Term Liabilities $130.0K $162.3K
YoY Change 8.34% -13.94%
Total Long-Term Liabilities $381.3K $451.7K
YoY Change -52.04% -53.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.55M $9.469M
Total Long-Term Liabilities $381.3K $451.7K
Total Liabilities $11.33M $10.39M
YoY Change 8.44% 15.54%
SHAREHOLDERS EQUITY
Retained Earnings -$2.366M -$255.7K
YoY Change 176.06% -64.62%
Common Stock $53.00 $53.00
YoY Change 1.92% 1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.053M $10.21M
YoY Change
Total Liabilities & Shareholders Equity $18.39M $20.60M
YoY Change -7.97% 12.52%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.110M $343.4K
YoY Change 1471.98% -491.22%
Depreciation, Depletion And Amortization $75.31K $85.53K
YoY Change -22.13% -11.44%
Cash From Operating Activities $1.140M $459.3K
YoY Change -29.31% -196.27%
INVESTING ACTIVITIES
Capital Expenditures $50.00K $18.88K
YoY Change -710.5% -112.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K -$18.88K
YoY Change 510.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.340M -186.4K
YoY Change 444.87% 37.36%
NET CHANGE
Cash From Operating Activities 1.140M 459.3K
Cash From Investing Activities -50.00K -18.88K
Cash From Financing Activities -1.340M -186.4K
Net Change In Cash -250.0K 254.0K
YoY Change -118.4% -141.45%
FREE CASH FLOW
Cash From Operating Activities $1.140M $459.3K
Capital Expenditures $50.00K $18.88K
Free Cash Flow $1.090M $440.4K
YoY Change -32.75% -234.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38063
dei Entity Registrant Name
EntityRegistrantName
SILVERSUN TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1633636
dei Entity Address Address Line1
EntityAddressAddressLine1
120 Eagle Rock Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
East Hanover
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07936
dei City Area Code
CityAreaCode
973
dei Local Phone Number
LocalPhoneNumber
396-1720
dei Security12g Title
Security12gTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
SSNT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5256177 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7129782 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8008633 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
422671 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
490311 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2227541 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2232960 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
501254 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
367165 usd
CY2023Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
2033774 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1516895 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1534037 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1573615 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
13426388 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13699268 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557104 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
711314 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
465042 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
328562 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3941431 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4265353 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1139952 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1139952 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
885719 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1106065 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187553 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187553 usd
CY2023Q2 us-gaap Assets
Assets
20603189 usd
CY2022Q4 us-gaap Assets
Assets
21438067 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2820595 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3272555 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2175225 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2432703 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
24129 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
23757 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
477069 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
680146 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
103333 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
103333 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
202420 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
214990 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
302739 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
268345 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3363654 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3757090 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9469164 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10752919 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
451674 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
671014 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
305235 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
401453 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162303 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60217 usd
CY2023Q2 us-gaap Liabilities
Liabilities
10388376 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11885603 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5256177 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5256177 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5256177 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5256177 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
53 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
53 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10470498 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10429001 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255738 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-876590 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10214813 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552464 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20603189 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21438067 usd
CY2023Q2 us-gaap Revenues
Revenues
13257271 usd
CY2022Q2 us-gaap Revenues
Revenues
10638073 usd
us-gaap Revenues
Revenues
26385009 usd
us-gaap Revenues
Revenues
21661917 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
8072126 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
6510805 usd
us-gaap Cost Of Revenue
CostOfRevenue
15842304 usd
us-gaap Cost Of Revenue
CostOfRevenue
12829782 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
5185145 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
4127268 usd
us-gaap Gross Profit
GrossProfit
10542705 usd
us-gaap Gross Profit
GrossProfit
8832135 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2141468 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1852903 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4320171 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3628714 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2383784 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2071145 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4943812 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4712122 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
45945 usd
us-gaap Share Based Compensation
ShareBasedCompensation
41497 usd
us-gaap Share Based Compensation
ShareBasedCompensation
91890 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
203629 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
236521 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
411424 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
498371 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
4728881 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4206514 usd
us-gaap Operating Expenses
OperatingExpenses
9716904 usd
us-gaap Operating Expenses
OperatingExpenses
8931097 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
456264 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-79246 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
825801 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-98962 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
17422 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
23800 usd
us-gaap Interest Expense
InterestExpense
34677 usd
us-gaap Interest Expense
InterestExpense
42652 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17422 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23800 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34677 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42652 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
438842 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103046 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
791124 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141614 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95481 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15280 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170272 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13192 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
343361 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-87766 usd
us-gaap Net Income Loss
NetIncomeLoss
620852 usd
us-gaap Net Income Loss
NetIncomeLoss
-128422 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5256177 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5136177 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5256177 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5136177 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9871452 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
343361 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10214813 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
9362112 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
45945 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-87766 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
9320291 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9552464 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
41497 usd
us-gaap Net Income Loss
NetIncomeLoss
620852 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10214813 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
9356823 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
91890 usd
us-gaap Net Income Loss
NetIncomeLoss
-128422 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
9320291 usd
us-gaap Profit Loss
ProfitLoss
620852 usd
us-gaap Profit Loss
ProfitLoss
-128422 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-220346 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
13192 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
178070 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
195007 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
323922 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
376822 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
188161 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
453009 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-67640 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41497 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91890 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-73059 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
319307 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
134089 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
60864 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
516879 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-39578 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
227664 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-1942 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-451960 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-95350 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-257478 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-303852 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
372 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-5405 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-393436 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3087 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
188161 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
453009 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-323786 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-485308 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23860 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30549 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
150000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23860 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-180549 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
422417 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
161240 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
108788 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
113346 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-531205 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
343361 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-274586 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-878851 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-940443 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8008633 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6814117 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7129782 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5873674 usd
us-gaap Interest Paid Net
InterestPaidNet
58248 usd
us-gaap Interest Paid Net
InterestPaidNet
48147 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
23479 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
15820 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
108330 usd
CY2022Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
73672 usd
CY2022Q2 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
494383 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Use of Estimates </span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5256177 shares
CY2023Q2 us-gaap Revenues
Revenues
13257271 usd
CY2022Q2 us-gaap Revenues
Revenues
10638073 usd
us-gaap Revenues
Revenues
26385009 usd
us-gaap Revenues
Revenues
21661917 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87766 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Concentrations</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash with various institutions, which exceed federally insured limits throughout the year. At June 30, 2023 and December 31, 2022, the Company had cash on deposit of $6,030,908 and $7,050,862, respectively, in excess of the federally insured limits of $250,000.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of June 30, 2023, no one customer represented more than 10% of the total accounts receivable and unbilled services. As of December 31, 2022, no one customer represented more than 10% of the total accounts receivable and unbilled services.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the six months ended June 30, 2023 and 2022, the Company’s top ten customers accounted for 10% ($2,681,200) and 9% ($1,856,981), respectively, of total revenues. The Company does not rely on any one specific customer for any significant portion of its revenue.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the six months ended June 30, 2023 and 2022 purchases from one supplier through a “channel partner” agreement were approximately 14% and 14% of cost of revenues, respectively. The channel partner agreements are for a one-year term and automatically renew for an additional one-year term on the anniversary of the agreement’s effective date.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of June 30, 2023, one supplier represented approximately 22% of total accounts payable. For the year ended December 31, 2022, one supplier represented approximately 28% of total accounts payable.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and cash. As of June 30, 2023, the Company believes it has no significant risk related to its concentration of credit risk related to accounts receivable.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6030908 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
7050862 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
343361 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87766 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5136177 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
620852 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-128422 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.12
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
620852 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-128422 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5256177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5136177 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5256177 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5136177 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.12
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
158420 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
165620 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
158420 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162020 shares
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
490311 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
330311 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
25000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
170178 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
92640 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
10178 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
422671 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
490311 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4011136 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3987276 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3454032 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3275962 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557104 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
711314 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85529 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
178070 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96582 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
195007 usd
CY2022Q1 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
1335000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
500000 usd
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
835000 usd
CY2022Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0325 pure
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8133365 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8133365 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4191934 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3868012 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3941431 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4265353 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
161961 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
323922 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
186365 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
376822 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
323922 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
647844 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
644367 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
633165 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
619516 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1072617 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3941431 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1032076 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1454493 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
580402 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
783479 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
361062 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
360091 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
258736 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
52187 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1032076 usd
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0724 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M24D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y5M8D
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
122905 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
176686 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
886000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1106000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95481 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170272 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15280 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
115080 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
115080 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
47950 usd
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
577701 usd
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
70046 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
507655 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
202420 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
305235 usd
ssnt Number Of Locations Of Office Space Leases
NumberOfLocationsOfOfficeSpaceLeases
4 pure
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
108330 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0477 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M2D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M8D
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
188485 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
197163 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
72058 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
30786 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
488492 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23450 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
465042 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
302739 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
162303 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
103213 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
213080 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
123086 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
258217 usd
CY2019Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
2000000 shares
CY2021Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
5000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13192 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
165620 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.256
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7200 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.53
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
158420 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.245
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
158420 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.245
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41497 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45945 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
91890 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
41497 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5000000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
103333 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
103333 usd
CY2023Q3 ssnt Termination Fee
TerminationFee
5000000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Central Index Key
EntityCentralIndexKey
0001236275

Files In Submission

Name View Source Status
0001185185-23-000784-index-headers.html Edgar Link pending
0001185185-23-000784-index.html Edgar Link pending
0001185185-23-000784.txt Edgar Link pending
0001185185-23-000784-xbrl.zip Edgar Link pending
ex_554909.htm Edgar Link pending
ex_554910.htm Edgar Link pending
ex_554911.htm Edgar Link pending
ex_554912.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
silversun20230630_10q.htm Edgar Link pending
ssnt-20230630.xsd Edgar Link pending
ssnt-20230630_def.xml Edgar Link unprocessable
ssnt-20230630_lab.xml Edgar Link unprocessable
ssnt-20230630_pre.xml Edgar Link unprocessable
silversun20230630_10q_htm.xml Edgar Link completed
ssnt-20230630_cal.xml Edgar Link unprocessable